His multidisciplinary approach integrates Internal medicine and Pathology in his work. He combines Pathology and Internal medicine in his studies. He merges Kidney disease with Creatinine in his research. He merges Creatinine with Renal function in his research. By researching both Renal function and Kidney, he produces research that crosses academic boundaries. His study deals with a combination of Kidney and Diabetes mellitus. He merges Diabetes mellitus with Nephropathy in his research. His research ties End stage renal disease and Disease together. His research on End stage renal disease frequently links to adjacent areas such as Disease.
His work often combines Internal medicine and Surgery studies. His study deals with a combination of Kidney disease and Kidney. He performs multidisciplinary study in Kidney and Kidney disease in his work. Adeera Levin undertakes interdisciplinary study in the fields of Dialysis and Nephrology through his research. His multidisciplinary approach integrates Nephrology and Dialysis in his work. He incorporates Renal function and Creatinine in his research. Adeera Levin integrates Creatinine with Renal function in his research. His research is interdisciplinary, bridging the disciplines of Population and Environmental health. His Population study frequently draws parallels with other fields, such as Environmental health.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Acute Kidney Injury Network: Report of an Initiative to Improve Outcomes in Acute Kidney Injury
Ravindra L Mehta;John A Kellum;Sudhir V Shah;Bruce A Molitoris.
Critical Care (2007)
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Andrew S. Levey;Kai-Uwe Eckardt;Yusuke Tsukamoto;Adeera Levin.
Kidney International (2005)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic;Vlado Perkovic;Meg J. Jardine;Meg J. Jardine;Bruce Neal;Bruce Neal;Bruce Neal;Severine Bompoint.
The New England Journal of Medicine (2019)
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
Colin Baigent;Martin J Landray;Christina Reith;Jonathan Emberson.
The Lancet (2011)
Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
A Levin;PE Stevens;RW Bilous;J Coresh.
Kidney International (2013)
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
A.S. Levey;R. Atkins;J. Coresh;E.P. Cohen.
Kidney International (2007)
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
A. Levin;G. L. Bakris;Mark E Molitch;M. Smulders.
Kidney International (2007)
Bone metabolism and disease in chronic kidney disease
Garabed Eknoyan;Adeera Levin;Nathan W Levin.
American Journal of Kidney Diseases (2003)
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.
Adeera Levin;Christopher R. Thompson;Jean Ethier;Euan J.F. Carlisle.
American Journal of Kidney Diseases (1999)
Evolving importance of kidney disease: from subspecialty to global health burden
Kai Uwe Eckardt;Josef Coresh;Olivier Devuyst;Richard J. Johnson.
The Lancet (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: